Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 286.00
Bid: 286.50
Ask: 291.00
Change: 22.50 (8.54%)
Spread: 4.50 (1.571%)
Open: 262.00
High: 295.00
Low: 262.00
Prev. Close: 263.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Perstorp Belgium

6 Mar 2017 07:02

RNS Number : 5461Y
Synthomer PLC
06 March 2017
 

The Company considers this announcement to contain inside information

 

6 March 2017

Synthomer plc

Acquisition of Perstorp Oxo Belgium AB

 

Synthomer plc (LSE:SYNT) ('Synthomer' or the 'Group'), a leading speciality chemicals company, today announces the acquisition of Perstorp Oxo Belgium AB ('Perstorp Belgium') from The Perstorp Group, a speciality chemicals innovator and supplier based in Sweden.

 

Synthomer will pay an enterprise value of €78 million which will be fully funded from existing financial resources. The acquisition, which completed on 5 March, represents a multiple of 8.5x 2016 Adjusted EBITDA(1). This is expected to fall to approximately 7.0x EBITDA post integration reflecting operational efficiencies and increased volumes to existing customers. Perstorp Belgium will be consolidated into Synthomer's results from March 2017.

 

In the year to 31 December 2016, Perstorp Belgium generated reported earnings before interest and tax of €8 million. At 31 December 2016, Perstorp Belgium had gross assets of €21 million.

 

Perstorp Belgium is a niche performance additives business serving the decorative and industrial coatings industries. It has strong market leadership positions (#1 or #2) and serves a highly attractive, blue-chip customer base. The business operates from a well located, single site in Ghent, Belgium where there is potential for growth capacity for future demand.

 

Perstorp Belgium is highly complementary to Synthomer's existing markets and customers. The Group will focus on expanding Perstorp Belgium's market position by developing closer relationships with customers through leveraging its existing sales and technical services infrastructure, and driving operational performance.

 

Calum MacLean, Chief Executive Officer of Synthomer, commented:

"The acquisition of Perstorp Belgium represents another step forward in our strategy to continue to grow and develop Synthomer. The business is an excellent fit and provides increased access to new products and customers. We look forward to welcoming our new colleagues and integrating the business with Synthomer through the remainder of this year."

 

Note 1 - Reported EBITDA of €8.8m excluding certain Perstorp Group overhead cost allocations of €0.3m resulting in Adjusted EBITDA of €9.1m

 

-Ends-

Enquiries:

Calum MacLean, Chief Executive Officer

Tel: 01279 436211

Stephen Bennett, Chief Financial Officer

Tel: 01279 436211

Charles Armitstead, Teneo Blue Rubicon

Tel: 020 3603 5220

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFIDVRIEIID
Date   Source Headline
19th Jul 20217:00 amRNSTrading Update
14th Jul 202111:02 amRNSDirector/PDMR Shareholding
9th Jul 20217:00 amRNSAppointment of Non-Executive Director
6th Jul 202112:37 pmRNSDirector/PDMR Shareholding
25th Jun 202110:01 amRNSFurther re Appointment of Group CEO
23rd Jun 20217:00 amRNSAppointment of Group Chief Executive Officer
18th May 20213:53 pmRNSDirector Declaration
12th May 20212:56 pmRNSDirector Declaration
6th May 20214:17 pmRNSDirector Declaration
6th May 20213:15 pmRNSDirector/PDMR Shareholding
29th Apr 20214:01 pmRNSResult of AGM
21st Apr 20217:00 amRNSQ1 Trading Update
31st Mar 20219:00 amRNSDirector/PDMR Shareholding
31st Mar 20219:00 amRNSDirector/PDMR Shareholding
30th Mar 202110:56 amRNSAnnual Financial Report
19th Mar 20212:38 pmRNSDirector/PDMR Shareholding
12th Mar 20213:17 pmRNSDirector/PDMR Shareholding
12th Mar 20213:16 pmRNSDirector/PDMR Shareholding
12th Mar 20213:14 pmRNSDirector/PDMR Shareholding
12th Mar 20213:14 pmRNSDirector/PDMR Shareholding
11th Mar 20219:43 amRNSHolding(s) in Company
4th Mar 202112:43 pmRNSPreliminary results – correction
4th Mar 20217:00 amRNSPreliminary Results year ended 31 December 2020
1st Mar 202112:58 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSStatement RE: Press Speculation
22nd Feb 20214:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20214:35 pmRNSPrice Monitoring Extension
19th Feb 20213:38 pmRNSHolding(s) in Company
14th Jan 20217:00 amRNSPre-Close Trading Update and Board Update
12th Jan 20219:36 amRNSHolding(s) in Company
6th Jan 20219:10 amRNSDirector Declaration
4th Jan 202110:09 amRNSDirector Declaration
23rd Dec 20204:54 pmRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSAppointment of New Chair
18th Nov 20207:00 amRNSInvestor Seminar
17th Nov 20201:34 pmRNSDirector/PDMR Shareholding
16th Oct 202010:33 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSQ3 Trading Update
7th Oct 20209:20 amRNSHolding(s) in Company
4th Sep 20203:15 pmRNSDirector Declaration
6th Aug 20207:00 amRNSInterim Results for six months ended 30 June 2020
27th Jul 202010:00 amRNSPost Stabilisation Notice
16th Jul 20207:00 amRNSAppointment of Non-Executive Director
8th Jul 20204:16 pmRNSHolding(s) in Company
8th Jul 20204:14 pmRNSHolding(s) in Company
19th Jun 20207:00 amRNSSynthomer announces the pricing of senior notes
16th Jun 202011:54 amRNSPre Stabilisation Notice
16th Jun 202010:11 amRNSQ2 trading update
11th May 20205:21 pmRNSHolding(s) in Company
11th May 20209:03 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.